partnership collaboration legal document
Biotech

CSL inks $328M Memo deal for option on antibody engineering tech

The deal allows CSL to potentially exercise an option that would give Memo up to $328 million on sales milestones.
Zoey Becker Feb 9, 2026 2:00am
Grouping of tiles with human figures on them being separated representing layoffs

Genentech cut at least 489 jobs last year, new filing reveals

Feb 6, 2026 1:38pm
Article Primary Image 1jpg

The Data Multiplier Effect: The 4 Forces Changing Biometrics

Feb 9, 2026 8:00am
pause button on blue background

UniQure halts mid- to high-dosing for AAV gene therapy

Feb 6, 2026 10:56am
Parachute over ocean with sunset behind

Moderna CMO steps down in leadership mix-up—Chutes & Ladders

Feb 6, 2026 8:30am
dynamic arrows moving up

Priovant will move brepocitinib to phase 3 after midstage win

Feb 6, 2026 7:00am
More News

Agomab, SpyGlass head to Nasdaq with IPOs totaling $350M

Feb 6, 2026 4:04am

Fierce Biotech Layoff Tracker 2026: ARPA-H, GSK & more

Feb 5, 2026 2:55pm

Racing BMS and J&J, Bayer ties asundexian to 26% stroke decrease

Feb 5, 2026 12:15pm
Fierce Pharma

Astellas lifts forecast as Vyloy surge counters trial miss

Feb 5, 2026 11:00am